Your browser doesn't support javascript.
loading
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Garcia, Josep; Hurwitz, Herbert I; Sandler, Alan B; Miles, David; Coleman, Robert L; Deurloo, Regula; Chinot, Olivier L.
Afiliación
  • Garcia J; Global Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Electronic address: josep.garcia@roche.com.
  • Hurwitz HI; Genentech Inc., CA, USA.
  • Sandler AB; Genentech Inc., CA, USA.
  • Miles D; Mount Vernon Cancer Centre, London, UK.
  • Coleman RL; Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas, MD Anderson Cancer Center, TX, USA.
  • Deurloo R; Oncology Biomarker Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Chinot OL; Aix-Marseille University, Assistance Publique-Hopitaux de Marseille, Centre Hospitalo-Universitaire Timone, Service de Neuro-Oncologie, Marseille, France.
Cancer Treat Rev ; 86: 102017, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32335505
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bevacizumab / Neoplasias Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bevacizumab / Neoplasias Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2020 Tipo del documento: Article